Oragenics Inc (OGEN)
0.3258
-0.01
(-4.18%)
USD |
NYAM |
Nov 14, 16:00
0.3289
0.00 (0.00%)
After-Hours: 20:00
Oragenics Free Cash Flow (Quarterly): -1.544M for June 30, 2024
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -1.544M |
| March 31, 2024 | -3.064M |
| December 31, 2023 | -1.102M |
| September 30, 2023 | -1.503M |
| June 30, 2023 | -2.577M |
| March 31, 2023 | -2.109M |
| December 31, 2022 | -2.436M |
| September 30, 2022 | -3.813M |
| June 30, 2022 | -3.383M |
| March 31, 2022 | -5.724M |
| December 31, 2021 | -2.504M |
| September 30, 2021 | -4.604M |
| June 30, 2021 | -2.078M |
| March 31, 2021 | -4.327M |
| December 31, 2020 | -3.632M |
| September 30, 2020 | -4.666M |
| June 30, 2020 | -4.833M |
| March 31, 2020 | -3.823M |
| December 31, 2019 | -3.950M |
| September 30, 2019 | -3.378M |
| June 30, 2019 | -3.499M |
| March 31, 2019 | -2.211M |
| December 31, 2018 | -3.042M |
| September 30, 2018 | -2.515M |
| June 30, 2018 | -2.281M |
| Date | Value |
|---|---|
| March 31, 2018 | -1.367M |
| December 31, 2017 | -1.359M |
| September 30, 2017 | -1.340M |
| June 30, 2017 | -1.765M |
| March 31, 2017 | -1.900M |
| December 31, 2016 | -1.964M |
| September 30, 2016 | -1.598M |
| June 30, 2016 | -1.92M |
| March 31, 2016 | -1.620M |
| December 31, 2015 | -1.662M |
| September 30, 2015 | -1.304M |
| June 30, 2015 | -0.9653M |
| March 31, 2015 | -1.361M |
| December 31, 2014 | -1.271M |
| September 30, 2014 | -1.099M |
| June 30, 2014 | -1.696M |
| March 31, 2014 | -1.603M |
| December 31, 2013 | -1.220M |
| September 30, 2013 | -1.975M |
| June 30, 2013 | -2.007M |
| March 31, 2013 | -1.581M |
| December 31, 2012 | -1.741M |
| September 30, 2012 | -1.178M |
| June 30, 2012 | -1.150M |
| March 31, 2012 | -1.143M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-5.724M
Minimum
Mar 2022
-1.102M
Maximum
Dec 2023
-3.246M
Average
-3.383M
Median
Jun 2022
Free Cash Flow (Quarterly) Benchmarks
| Shuttle Pharmaceuticals Holdings Inc | -1.399M |
| Perspective Therapeutics Inc | -9.917M |
| Alaunos Therapeutics Inc | -1.681M |
| Cocrystal Pharma Inc | -3.699M |
| Cara Therapeutics Inc | -12.65M |